March 15, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
The latest scuttlebutt on the Walgreens-Rite Aid merger: Walgreens Boots Alliance looks to be divesting even more stores and other assets to Fred’s. Citing anonymous sources, Bloomberg reported Tuesday that WBA is “nearing an agreement” to raise the number of stores to sell to Fred’s as well as include distribution centers, software and staff. No
March 14, 2017 by CDR Blog and Chain Drug Review
Affordable Care Act, Genoa, John Figueroa, Managed Healthcare Executive
CDR Blog
Any repeal or replacement of the Affordable Care Act shouldn’t impinge on pharmacy benefits for mental health patients, Genoa CEO John Figueroa said in a column for Managed Healthcare Executive. Figueroa noted in the article that last month the Senate mulled proposal to scale back or cut access to mental health services. Such a move would
March 8, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
It has been over 14 months and two deal date extensions since the announcement of Walgreens Boots Alliance’s agreement to acquire Rite Aid Corp. Now WBA may act to push the Federal Trade Commission to come to a decision. The New York Post reported that WBA may claim that it has “certified compliance” in its
March 7, 2017 by CDR Blog and Chain Drug Review
Alistair Bursey, Canadian pharmacists, Canadian Pharmacists Association, Gallup Honesty and Integrity survey, Pharmacist Awareness Month
CDR Blog
Just as in the U.S., pharmacists are held in high regard in Canada, where consumers are increasingly seeing them as a broader health care provider. The Canadian Pharmacists Association (CPA) reports that 94% of Canadians have a positive view of pharmacists — more than doctors, teachers, military officers and police officers, according to an online
March 1, 2017 by CDR Blog and Chain Drug Review
Advisor Access, CVS Health, CVS Pharmacy, Dave Denton, Maintenance Choice 3.0, prescription drug prices, repeal of the Affordable Care Act, Target's pharmacy business
CDR Blog
CVS Health’s pharmacy care assets position the company well for growth, even in an evolving health care arena set for further change under a new presidential administration, executive VP and CFO Dave Denton said. In an interview posted this week on investment intelligence website Advisor Access, Denton outlined CVS’ strengths — namely, its integrated retail
February 22, 2017 by CDR Blog and Chain Drug Review
Apple Computer, High Point University, High Point University pharmacy students, HPU Fred Wilson School of Pharmacy, Steve Wozniak
CDR Blog
Though IT is his bailiwick, “Woz” looks to spur innovation beyond the technology realm. Just ask High Point University pharmacy students. Apple Computer co-founder, inventor and entrepreneur Steve Wozniak met with students and faculty from the North Carolina university on Tuesday in a series of micro sessions, starting with students from the HPU Fred Wilson
February 16, 2017 by CDR Blog and Chain Drug Review
Abbott "Tad" Lipsky, Federal Trade Commission, Fred's, FTC Bureau of Competition, Maureen Ohlhausen, New York Post, Walgreens-Rite Aid deal, Walgreens-Rite Aid merger
CDR Blog
After being announced well over a year ago and endless speculation, it looks like the Federal Trade Commission is set to sign off on Walgreens Boots Alliance’s planned acquisition of Rite Aid Corp. The New York Post reported late Wednesday evening that WBA is bullish that it’s latest store divestiture proposal will sway the FTC
February 8, 2017 by CDR Blog and Chain Drug Review
Abhi Dhar, Walgreens, Walgreens Boots Alliance, Walgreens CIO
CDR Blog
Walgreens CIO Abhi Dhar is slated to exit the company next month to lead an online marketing startup company focusing on the retail arena, according to CIO magazine. Walgreens declined to comment to CIO about a replacement for Dhar. Dhar’s LinkedIn page describes him as the co-founder and CEO of an Illinois-based digital startup that
February 8, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Drug Channels Institute, pharmaceutical supply chain, pharmacy industry, specialty drugs, specialty pharmacy
CDR Blog
The rapid growth of the specialty pharmacy sector, fueled by high-priced specialty drugs, remains one of the leading story lines in the pharmacy industry. Compared with the retail pharmacy arena, the field of players in the specialty Rx market has yet to shake out. But pharmaceutical supply chain and economics expert Adam Fein, CEO of
February 1, 2017 by CDR Blog and Chain Drug Review
American Pharmacists Association, APhA, Department of Health and Human Services, Donald Trump, HHS secretary nominee, Pharmacy and Medically Underserved Areas Enhancement Act, provider status, Tom Menighan, Tom Price
CDR Blog
Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
January 27, 2017 by CDR Blog and Chain Drug Review
Cerberus Capital Management, Federal Trade Commission, Fred's, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
As the clock winds down on today’s deal end date for the Walgreens-Rite Aid merger, a report of a new potential player has emerged. Citing anonymous sources, the New York Post reported Friday that private equity firm Cerberus Capital Management has expressed interest in the 865 Rite Aid stores that Walgreens Boots Alliance and Rite
January 27, 2017 by CDR Blog and Chain Drug Review
Diane Hayes, direct-to-consumer advertising for pharmaceuticals, DTC pharmaceutical ads, InCrowd, pharma industry
CDR Blog
Direct-to-consumer advertising for pharmaceuticals has led to a more “inquisitive” patient, but doctors are concerned about how these ads shape patients’ understanding of the medications, a new microsurvey by InCrowd finds. The physicians poll by InCrowd, a provider of real-time market intelligence to life sciences and health care firms, revealed that the estimated $5.4 billion
January 20, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Rite Aid shares, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Trading of Rite Aid shares was briefly halted on the New York Stock Exchange on Friday when the stock price sank following published reports that the Federal Trade Commission is iffy about antitrust concessions for approval of the Walgreens-Rite Aid merger. Rite Aid shares suspended trading after dropping 18% but resumed minutes later, TheStreet.com reported.
January 19, 2017 by CDR Blog and Chain Drug Review
drug formulary changes, Floridians for Reliable Health Coverage, Global Healthy Living Foundation, non-medical switching, prescription drug benefits
CDR Blog, Opinion
As anyone reading the headlines these days can see, the outlook for health care coverage is … well, a big question mark. Soon-to-be-president Donald Trump and Republican congressional leaders have made no bones about ushering the Affordable Care Act out the door. What they plan to replace it with remains up in the air. Yet